{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:15:13Z","timestamp":1772172913435,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008755","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000}}],"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA244613"],"award-info":[{"award-number":["R37CA244613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12CA076917"],"award-info":[{"award-number":["K12CA076917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1111032"],"award-info":[{"award-number":["APP1111032"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","award":["APP37138"],"award-info":[{"award-number":["APP37138"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008533","name":"Case Comprehensive Cancer Center, Case Western Reserve University","doi-asserted-by":"publisher","award":["Cancer Center Trainee Award"],"award-info":[{"award-number":["Cancer Center Trainee Award"]}],"id":[{"id":"10.13039\/100008533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM007250"],"award-info":[{"award-number":["T32GM007250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>MicroRNA (miRNA)-based therapies are an emerging class of targeted therapeutics with many potential applications. Ewing Sarcoma patients could benefit dramatically from personalized miRNA therapy due to inter-patient heterogeneity and a lack of druggable (to this point) targets. However, because of the broad effects miRNAs may have on different cells and tissues, trials of miRNA therapies have struggled due to severe toxicity and unanticipated immune response. In order to overcome this hurdle, a network science-based approach is well-equipped to evaluate and identify miRNA candidates and combinations of candidates for the repression of key oncogenic targets while avoiding repression of essential housekeeping genes. We first characterized 6 Ewing sarcoma cell lines using mRNA sequencing. We then estimated a measure of tumor state, which we term network potential, based on both the mRNA gene expression and the underlying protein-protein interaction network in the tumor. Next, we ranked mRNA targets based on their contribution to network potential. We then identified miRNAs and combinations of miRNAs that preferentially act to repress mRNA targets with the greatest influence on network potential. Our analysis identified TRIM25, APP, ELAV1, RNF4, and HNRNPL as ideal mRNA targets for Ewing sarcoma therapy. Using predicted miRNA-mRNA target mappings, we identified miR-3613-3p, let-7a-3p, miR-300, miR-424-5p, and let-7b-3p as candidate optimal miRNAs for preferential repression of these targets. Ultimately, our work, as exemplified in the case of Ewing sarcoma, describes a novel pipeline by which personalized miRNA cocktails can be designed to maximally perturb gene networks contributing to cancer progression.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1008755","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T19:50:39Z","timestamp":1634586639000},"page":"e1008755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma"],"prefix":"10.1371","volume":"17","author":[{"given":"Davis T.","family":"Weaver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen I.","family":"Pishas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1745-8846","authenticated-orcid":true,"given":"Drew","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-5735","authenticated-orcid":true,"given":"Jessica","family":"Scarborough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2388-0621","authenticated-orcid":true,"given":"Stephen L.","family":"Lessnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-1277","authenticated-orcid":true,"given":"Andrew","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-7673","authenticated-orcid":true,"given":"Jacob G.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"issue":"9","key":"pcbi.1008755.ref001","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/cbt.9.9.11511","article-title":"The molecular pathogenesis of Ewing\u2019s sarcoma","volume":"9","author":"C Mackintosh","year":"2010","journal-title":"Cancer biology & therapy"},{"issue":"6","key":"pcbi.1008755.ref002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MPH.0b013e31816e22f3","article-title":"Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades","volume":"30","author":"N Esiashvili","year":"2008","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"0","key":"pcbi.1008755.ref003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1615\/CritRevOncog.2015013553","article-title":"Twenty Years On\u2014What Do We Really Know About Ewing Sarcoma And What Is The Path Forward?","volume":"20","author":"ER Lawlor","year":"2015","journal-title":"Critical reviews in oncogenesis"},{"issue":"9","key":"pcbi.1008755.ref004","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1101\/gad.1899710","article-title":"EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells","volume":"24","author":"N Riggi","year":"2010","journal-title":"Genes & development"},{"issue":"3","key":"pcbi.1008755.ref005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"R Rupaimoole","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"pcbi.1008755.ref006","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1038\/s41467-018-07657-1","article-title":"Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors","volume":"9","author":"A Dhawan","year":"2018","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1008755.ref007","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"D Hanahan","year":"2000","journal-title":"cell"},{"issue":"6","key":"pcbi.1008755.ref008","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.3892\/or.2015.3895","article-title":"miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo","volume":"33","author":"X LIN","year":"2015","journal-title":"Oncology Reports"},{"issue":"3","key":"pcbi.1008755.ref009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/bjh.13043","article-title":"Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia","volume":"167","author":"K Lin","year":"2014","journal-title":"British Journal of Haematology"},{"issue":"1","key":"pcbi.1008755.ref010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40425-018-0436-5","article-title":"STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial","volume":"6","author":"MJ Reilley","year":"2018","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"314","key":"pcbi.1008755.ref011","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/scitranslmed.aac5272","article-title":"AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer","volume":"7","author":"D Hong","year":"2015","journal-title":"Science Translational Medicine"},{"issue":"7","key":"pcbi.1008755.ref012","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/1078-0432.CCR-16-1317","article-title":"Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity","volume":"23","author":"S Odate","year":"2017","journal-title":"Clinical Cancer Research"},{"issue":"21","key":"pcbi.1008755.ref013","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1158\/0008-5472.CAN-12-2001","article-title":"miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma","volume":"72","author":"AL Kasinski","year":"2012","journal-title":"Cancer research"},{"issue":"14","key":"pcbi.1008755.ref014","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","article-title":"Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34","volume":"70","author":"JF Wiggins","year":"2010","journal-title":"Cancer Research"},{"issue":"13","key":"pcbi.1008755.ref015","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1080\/15384101.2014.1003008","article-title":"Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation","volume":"14","author":"C Stahlhut","year":"2015","journal-title":"Cell Cycle"},{"issue":"2","key":"pcbi.1008755.ref016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"C Liu","year":"2011","journal-title":"Nature medicine"},{"key":"pcbi.1008755.ref017","unstructured":"Maciej Pajak TIS. miRNAtap: miRNAtap: microRNA Targets\u2014Aggregated Predictions.; 2019. Available from: https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/miRNAtap.html."},{"issue":"D1","key":"pcbi.1008755.ref018","doi-asserted-by":"crossref","first-page":"D146","DOI":"10.1093\/nar\/gku1104","article-title":"miRDB: an online resource for microRNA target prediction and functional annotations","volume":"43","author":"N Wong","year":"2015","journal-title":"Nucleic Acids Research"},{"issue":"Web Server","key":"pcbi.1008755.ref019","doi-asserted-by":"crossref","first-page":"W273","DOI":"10.1093\/nar\/gkp292","article-title":"DIANA-microT web server: elucidating microRNA functions through target prediction","volume":"37","author":"M Maragkakis","year":"2009","journal-title":"Nucleic Acids Research"},{"key":"pcbi.1008755.ref020","unstructured":"O\u2019Neill V. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection\u2014Full Text View\u2014ClinicalTrials.gov;. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01829971."},{"key":"pcbi.1008755.ref021","author":"X Lai","year":"2019","journal-title":"Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer"},{"issue":"12","key":"pcbi.1008755.ref022","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.18632\/oncotarget.12932","article-title":"Personalized anticancer therapy selection using molecular landscape topology and thermodynamics","volume":"8","author":"EA Rietman","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"pcbi.1008755.ref023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10867-016-9410-y","article-title":"Thermodynamic measures of cancer: Gibbs free energy and entropy of protein-protein interactions","volume":"42","author":"EA Rietman","year":"2016","journal-title":"Journal of biological physics"},{"key":"pcbi.1008755.ref024","first-page":"139","author":"E Rietman","year":"2018"},{"issue":"9","key":"pcbi.1008755.ref025","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/1535-7163.MCT-18-0373","article-title":"Therapeutic targeting of KDM1A\/LSD1 in ewing sarcoma with SP-2509 engages the endoplasmic reticulum stress response","volume":"17","author":"KI Pishas","year":"2018","journal-title":"Molecular Cancer Therapeutics"},{"issue":"5","key":"pcbi.1008755.ref026","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/2159-8290.CD-20-1230","article-title":"St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem","volume":"11","author":"C McLeod","year":"2021","journal-title":"Cancer Discovery"},{"issue":"D1","key":"pcbi.1008755.ref027","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"R Oughtred","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"pcbi.1008755.ref028","doi-asserted-by":"crossref","first-page":"e85150","DOI":"10.1371\/journal.pone.0085150","article-title":"Transforming RNA-Seq Data to Improve the Performance of Prognostic Gene Signatures","volume":"9","author":"I Zwiener","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"pcbi.1008755.ref029","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biology"},{"issue":"3","key":"pcbi.1008755.ref030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the Dependency of Cellular Protein Levels on mRNA Abundance","volume":"165","author":"Y Liu","year":"2016","journal-title":"Cell"},{"issue":"4","key":"pcbi.1008755.ref031","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"C Vogel","year":"2012","journal-title":"Nature Reviews Genetics"},{"key":"pcbi.1008755.ref032","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.7717\/peerj.270","article-title":"System wide analyses have underestimated protein abundances and the importance of transcription in mammals","volume":"2","author":"JJ Li","year":"2014","journal-title":"PeerJ"},{"issue":"6226","key":"pcbi.1008755.ref033","doi-asserted-by":"crossref","first-page":"1259038","DOI":"10.1126\/science.1259038","article-title":"Dynamic profiling of the protein life cycle in response to pathogens","volume":"347","author":"M Jovanovic","year":"2015","journal-title":"Science"},{"issue":"2","key":"pcbi.1008755.ref034","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"DP Nusinow","year":"2020","journal-title":"Cell"},{"issue":"6794","key":"pcbi.1008755.ref035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/35019019","article-title":"Error and attack tolerance of complex networks","volume":"406","author":"R Albert","year":"2000","journal-title":"Nature"},{"issue":"1","key":"pcbi.1008755.ref036","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41598-017-00791-8","article-title":"Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer","volume":"7","author":"A Dhawan","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"pcbi.1008755.ref037","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/gb-2003-5-1-r1","article-title":"MicroRNA targets in Drosophila","volume":"5","author":"AJ Enright","year":"2003","journal-title":"Genome Biology"},{"issue":"5","key":"pcbi.1008755.ref038","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cub.2006.01.050","article-title":"A Genome-Wide Map of Conserved MicroRNA Targets in C. elegans","volume":"16","author":"S Lall","year":"2006","journal-title":"Current Biology"},{"issue":"1","key":"pcbi.1008755.ref039","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"RC Friedman","year":"2008","journal-title":"Genome Research"},{"key":"pcbi.1008755.ref040","doi-asserted-by":"crossref","unstructured":"Eisenberg E, Levanon EY. Human housekeeping genes, revisited; 2013. Available from: http:\/\/dx.doi.org\/10.1016\/j.tig.2013.05.010.","DOI":"10.1016\/j.tig.2013.05.010"},{"issue":"D1","key":"pcbi.1008755.ref041","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"JG Tate","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"pcbi.1008755.ref042","first-page":"1","volume-title":"Current Protocols in Bioinformatics","author":"G Stelzer","year":"2016"},{"issue":"12","key":"pcbi.1008755.ref043","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"A Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"6","key":"pcbi.1008755.ref044","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"1","author":"A Liberzon","year":"2015","journal-title":"Cell Systems"},{"key":"pcbi.1008755.ref045","first-page":"060012","article-title":"An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation","author":"G Korotkevich","year":"2016","journal-title":"bioRxiv"},{"issue":"1","key":"pcbi.1008755.ref046","first-page":"289","article-title":"Controlling the False Discovery Rate\u2014a Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B-Methodological 1995.pdf. Journal of the Royal Statistical Society Series B (Methological)"},{"issue":"10","key":"pcbi.1008755.ref047","doi-asserted-by":"crossref","first-page":"1002941","DOI":"10.1371\/journal.pgen.1002941","article-title":"MOV10 RNA Helicase Is a Potent Inhibitor of Retrotransposition in Cells","volume":"8","author":"JL Goodier","year":"2012","journal-title":"PLoS Genetics"},{"issue":"32","key":"pcbi.1008755.ref048","doi-asserted-by":"crossref","first-page":"33834","DOI":"10.18632\/oncotarget.5616","article-title":"The association between let-7, RAS and HIF-1 in Ewing Sarcoma tumor growth","volume":"6","author":"M Hameiri-Grossman","year":"2015","journal-title":"Oncotarget"},{"issue":"17","key":"pcbi.1008755.ref049","doi-asserted-by":"crossref","first-page":"28226","DOI":"10.18632\/oncotarget.15999","article-title":"MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer","volume":"8","author":"M Guo","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"pcbi.1008755.ref050","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.18632\/oncotarget.6821","article-title":"MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer","volume":"7","author":"R Tang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"pcbi.1008755.ref051","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s13277-013-1114-3","article-title":"A let-7 KRAS rs712 polymorphism increases colorectal cancer risk","volume":"35","author":"XM Pan","year":"2014","journal-title":"Tumor Biology"},{"key":"pcbi.1008755.ref052","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.biopha.2018.03.005","article-title":"miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK\/PI3K\/AKT signaling pathway","volume":"103","author":"R Wang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"30","key":"pcbi.1008755.ref053","doi-asserted-by":"crossref","first-page":"29413","DOI":"10.18632\/oncotarget.5003","article-title":"The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53\/PTTG1 regulation feedback loop","volume":"6","author":"Hq Liang","year":"2015","journal-title":"Oncotarget"},{"key":"pcbi.1008755.ref054","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biopha.2018.03.018","article-title":"miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer","volume":"102","author":"J Wang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"pcbi.1008755.ref055","article-title":"MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc","author":"J Zhao","year":"2018","journal-title":"European review for medical and pharmacological sciences"},{"issue":"4","key":"pcbi.1008755.ref056","article-title":"The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p","volume":"3","author":"C Alderman","year":"2016","journal-title":"RNA & disease (Houston, Tex)"},{"key":"pcbi.1008755.ref057","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biochi.2018.07.023","article-title":"miR-590\u20133p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells","volume":"154","author":"M Rohini","year":"2018","journal-title":"Biochimie"},{"issue":"3","key":"pcbi.1008755.ref058","doi-asserted-by":"crossref","first-page":"101042831769594","DOI":"10.1177\/1010428317695947","article-title":"MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1","volume":"39","author":"X Ge","year":"2017","journal-title":"Tumor Biology"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008755","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T14:12:39Z","timestamp":1637244759000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008755"}},"subtitle":[],"editor":[{"given":"Zhaolei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008755","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/854695","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}